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In late 2015, the World Health Organization 
(WHO) announced new “treat all” guidelines, 
recommending that anyone who has tested 
positive for HIV should begin antiretroviral 
treatment (ART) as soon as possible.1 The 
Government of Namibia adopted these guidelines 
and included treat all in their 2016 National 
Guidelines for ART;2 nationwide implementation 
began in April 2017. There is a need to understand 
how the implementation of these new guidelines 
affects critical aspects of ART service quality as 
reflected by patient-level outcomes including 
12-month retention, appointment attendance, and 
viral suppression, and health system outcomes 
(i.e., human and financial resources for health).
Besides the implementation of the treat 
all guidelines, the Namibian government 
began piloting ART task shifting and service 
decentralization since 2011 and officially adopted 
task-shifting guidelines in 2015. This process 
involves transferring stable ART clients from 
district-level hospitals to smaller community 
health centers and devolving specific point-of-
care responsibilities from physicians to nurses. 
Task shifting intends to help the country’s health 
system cope with the severe shortage of medical 
staff while service decentralization aims to expand 
access to ART in rural areas—each simultaneously 
reducing patient loads in often heavily burdened 
central health centers.
This brief highlights baseline data collected as 
part of a larger study assessing the impact of 
implementing the treat-all guidelines on key 
treatment and health system outcomes. The 
second round of data collection will be completed 
in June–July 2018. The baseline data provide 
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Baseline data findings will inform a larger Project SOAR study 
assessing the impact of implementing the treat-all guidelines 
on key treatment and health system outcomes in Namibia.
KEY MESSAGES
•• Overall, data from 10 selected ART sites 
show that the Namibian government 
is progressing toward achieving the 
UNAIDS 90-90-90 targets.
•• Providing services through 
decentralized, community-based health 
facilities can expand access to HIV care 
and treatment in rural areas without 
compromising key patient outcomes. 
This effort should be continued. 
•• Additional research is needed to better 
understand why only 60 percent of ART 
patients had records of viral load data 
and to identify solutions to close this 
gap. 
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PROFILE OF PEOPLE RECEIVING 
ART SERVICES   
Hospital 
(Central)
Clinic 
(Decentral)
Sex
66%  
female
72%  
female
Age
Mean* 41 years old
44 years 
old
Marital 
status
Single/unmarried 
(incl. divorced, 
widowed, 
separated)**
68% 56%
Married/in union 27% 38%
Patient 
type
New ART 29% 13%
Existing ART 71% 87%
Overall, women comprised over two-thirds of the 
sample, but gender differences between the two 
facility types was not significant. On average, 
patients at central facilities were 2.5 years 
younger, more likely to be single/unmarried, and 
new ART patients compared to their decentralized 
counterparts. Patients’ median time on ART 
across both facilities was 5.5–5.7 years. 
RESULTS
Health facilities achieved >90 percent 
patient retention over 12 months, but more 
than a third of patients missed at least one 
scheduled ART refill visit (Figure 1). 
a snapshot of ART services delivered by health 
facilities in northern Namibia during the year 
prior to the rollout of the treat all guidelines. We 
also examine ART service outcomes, including 
12-month ART patient retention, viral load (VL) 
testing, and viral suppression, to determine the 
effects of service decentralization during the year 
preceding the national roll-out of Namibia’s treat 
all recommendations. 
METHODS
We selected six central district hospitals (defined 
as centralized sites) and four community-based 
health centers (defined as decentralized sites) 
from six districts in northern Namibia (Andara, 
Nyangana, Oshikuku, Onandjokwe, Tsumeb, and 
Omuthiya). These 10 selected facilities have 
received technical assistance for HIV clinical 
services from IntraHealth International (UTAP 
Project) since 2015.
We abstracted information on clinical visits, 
scheduled appointments, drug dispensing, and 
VL tests from the records of 949 patients for the 
period 1 April 2016 to 31 March 2017. 
DEFINITIONS
Because the length of time on ART may affect 
treatment outcomes, we stratified ART patients as 
follows: 
•• New ART patients: those who initiated ART 
between 1 January and 31 March 2016. 
•• Existing ART patients: those who initiated 
treatment prior to 1 January 2016.
Viral suppression: having a VL test 
result of < 1,000 copies/ml
Undetectable VL: having VL test result 
of < 50 copies/ml. 
*p<0.01; **p<0.001 
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Patients at central facilities were more 
likely to have received a VL test than 
patients at decentralized sites. 
Overall, the records of less than two-thirds 
of patients (60 percent) at either facility type 
indicated that a VL test had been conducted 
during the 12 months prior to treat all 
implementation. Patients at central hospitals and 
clinics were significantly more likely to have a VL 
test result recorded than patients at decentralized 
sites (64 vs 52 percent; Figure 2). Records of VL 
testing did not differ among new and existing ART 
patients nor between female and male patients. 
Viral suppression was high among patients 
tested in both types of facilities.
Among the 566 patients with documented test 
results, VL outcomes did not vary significantly 
between facility types (Figure 2). Overall, 90 
percent of tested clients were virally suppressed, 
and 85 percent had undetectable viral loads. 
Figure 2  Client-level VL outcomes during past 12 months 
52%
64%
90%
93%
84%
85%
Received VL test** Achieved viral suppresssion† Achieved undectable VL†
Centralized Decentralized
Figure 1  Client-level care outcomes during the past 12 months 
Centralized
Decentralized
Retained in care Missed ≥1 scheduled visits
93%
90%
38%
33%
 **p<0.001; †among 566 clients who received VL test in past 12 months 
CONCLUSION
These data show that the facilities surveyed 
reached two critical milestones: over 90 percent 
of ART patients were retained in care after 12 
months and 90 percent of clients who received a 
VL test had achieved viral suppression. 
The comparability of patient retention and 
viral suppression between centralized and 
decentralized sites suggests that the quality of 
basic ART services available through primary 
health care centers in rural Namibia is likely 
similar to services in larger hospitals. Therefore, 
service decentralization merits further attention 
and investment as a mode of improving access 
to HIV care and treatment services in Namibia, 
particularly as treat all enables more patients to 
initiate ART. 
Despite these successes, there is room for 
improvement. Forty percent of all ART patients 
in our sample had no record of VL testing during 
the 12 months preceding treat all adoption. If, 
in fact, 40 percent of patients did not have a 
VL test in the preceding year, this may facilitate 
the development of drug resistance by allowing 
treatment failure to go unnoticed. Moreover, VL 
testing was one measure in which decentralized 
health centers lag considerably behind district 
hospitals.
While there were no significant differences in HIV 
outcomes between male and female patients, 
the difference in ART uptake by men and women 
is notable, particularly in decentralized facilities 
where 72 percent of our sample were women. This 
difference may suggest a need to examine why 
many men living with HIV are not accessing ART 
care and how services can better attract men. 
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RECOMMENDATIONS
The Government of Namibia should continue 
to expand task-shifting and service 
decentralization in order to make HIV 
services more efficient and accessible.
The high rates of patient retention and VL 
suppression observed, and comparability of 
ART outcomes across facility types suggest that 
decentralizing ART services is effective and may 
help expand access to ART under treat all. The 
resultant progress toward achieving UNAIDS 90-
90-90 targets is commendable. 
Additional support is needed to understand 
the factors contributing to low recording 
of VL testing, particularly in decentralized 
clinics. 
It would also be useful to conduct a focused study 
of viral suppression levels among patients with no 
recorded VL test results.
Additional analysis is needed to understand 
whether missing a scheduled ART visit 
is associated with a gap in antiretroviral 
medication adherence as well as other 
clinical outcomes.
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